Atef, M., A. Y. El-Gendi, M. M. Aziza, and E. - A. A. M. Abd,
"Pharmacokinetic properties of florfenicol in Egyptian goats.",
DTW. Deutsche tierarztliche Wochenschrift, vol. 107, no. 4, pp. 147–150, 2000.
Abstractn/a
Bando, M., N. Shibahara, Y. Shimada, M. R. Meselhy, T. Akao, T. Itoh, and K. Terasawa,
"Pharmacokinetic study of paeoniflorin, paeonimetabolin-I and glycyrrhetic acid in humans after oral administration of paeony root, Glycyrrhiza and Shakuyaku-kanzo-to (Shao-Yao-Gan-Cao-Tang).",
Journal of Traditional Medicines, vol. 17, issue 1, pp. 26-33, 2000.
Abstractn/a
Abo El-Sooud, K., H. A. El-Banna, M. S. M. Hanafy, and A. Goudah,
"Pharmacokinetics and intramuscular bioavailability of cefuroxime sodium in goats",
Research in Veterinary Science, vol. 69, no. 3, pp. 219-224, 2000.
Abstractn/a
Khaled, H. M., M. R. Hamza, O. Mansour, R. Gaafar, and M. S. Zaghloul,
"A phase II study of gemcitabine plus cisplatin chemotherapy in advanced bilharzial bladder carcinoma",
European Journal of Cancer, vol. 36, no. SUPPL. 2, pp. S34-S37, 2000.
AbstractBilharzial bladder cancer represents a distinct clinicopathological entity. To investigate whether gemcitabine-cisplatin is also active against bladder cancer of bilharzial origin, we performed a phase II study of previously untreated patients with stage III/IV disease. Standard eligibility criteria were used. Patients received gemcitabine (1000 mg/m2) on days 1, 8 and 15 and cisplatin (70 mg/m2) on day 2 of every 28-day cycle. The 32 males and 5 females had a median age of 59 years (range: 29-81 years). Of 33 evaluable patients, 8 (24%) achieved complete responses, and 10 (30%) partial responses, for an overall response rate of 55%. 3 patients had minor responses. Responses were observed at all disease sites including lung and liver lesions. Myelosuppression was significant but manageable. Non-haematological toxicity was limited mainly to nausea and vomiting and raised liver enzymes. Thus, these data suggest that gemcitabine plus cisplatin induces high response rates in patients with bilharzial bladder cancer with a moderate toxicity profile. Copyright (C) 2000.
Khaled, H. M., M. R. Hamza, O. Mansour, R. Gaafar, and M. S. Zaghloul,
"A phase II study of gemcitabine plus cisplatin chemotherapy in advanced bilharzial bladder carcinoma",
European Journal of Cancer, vol. 36, no. SUPPL. 2, pp. S34-S37, 2000.
AbstractBilharzial bladder cancer represents a distinct clinicopathological entity. To investigate whether gemcitabine-cisplatin is also active against bladder cancer of bilharzial origin, we performed a phase II study of previously untreated patients with stage III/IV disease. Standard eligibility criteria were used. Patients received gemcitabine (1000 mg/m2) on days 1, 8 and 15 and cisplatin (70 mg/m2) on day 2 of every 28-day cycle. The 32 males and 5 females had a median age of 59 years (range: 29-81 years). Of 33 evaluable patients, 8 (24%) achieved complete responses, and 10 (30%) partial responses, for an overall response rate of 55%. 3 patients had minor responses. Responses were observed at all disease sites including lung and liver lesions. Myelosuppression was significant but manageable. Non-haematological toxicity was limited mainly to nausea and vomiting and raised liver enzymes. Thus, these data suggest that gemcitabine plus cisplatin induces high response rates in patients with bilharzial bladder cancer with a moderate toxicity profile. Copyright (C) 2000.
Abdel-Sattar, E., M. A. Kohiel, I. A. Shehata, O. A. Rashwan, and H. El-Askary,
"PHENOLIC (CONSTITUENTS OF GYMNARRHENA MICRANTHA DESE.",
Bull. Fac. Pharm. Cairo Univ, vol. 38, no. 1, pp. 137–140, 2000.
Abstractn/a
Abdel-Sattar, E., M. A. Kohiel, I. A. Shihata, and H. El-Askary,
"Phenolic compounds from Eucalyptus maculata.",
Die Pharmazie, vol. 55, no. 8, pp. 623–624, 2000.
Abstractn/a
Ahmed, A. S., N. Nakamura, M. R. Meselhy, M. A. Makhboul, N. El-Emary, and M. Hattori,
"Phenolic constituents from Grevillea robusta",
Phytochemistry, vol. 53, issue 1: Pergamon, pp. 149-154, 2000.
Abstractn/a
Rashwan, M., O. A. M. K.,
"Phonetic Speech Segmentation for Verification Using Hidden Markov Model",
International Conference on Signals Processing Application & Technology (ICSPAT2000), no. 4- Rashwan, M., A., Omar, M., K., Phonetic Speech: Dallas, TX., USA, 2000.
Abstractn/a
EL-SHEMY, H. A., H. YAMANA, H. Saneoka, and K. Fujita,
"Phylogenetic comparative analysis of storage protein structure in legume seeds",
American biotechnology laboratory, vol. 18, issue 11: International Scientific Communications, pp. 60-62, 2000.
Abstractn/a
Dark, M. L., L. T. Perelman, I. Itzkan, J. L. Schaffer, and M. S. Feld,
"Physical properties of hydrated tissue determined by surface interferometry of laser-induced thermoelastic deformation",
Physics in Medicine & Biology, vol. 45, issue 2: IOP Publishing, pp. 529, 2000.
Abstractn/a
Dawood, K. M., A. M. Farag, E. A. Ragab, and Z. E. Kandeel,
"Polyheterocyclic ring systems with bridgehead nitrogen atoms: a facile route to some novel Azolo-1, 2, 4-triazine derivatives",
Journal of Chemical Research, vol. 2000, no. 5: SAGE Publications Sage UK: London, England, pp. 206–207, 2000.
Abstractn/a
S., A. - B., M. A. M. Ibrahim, and U. M. El-Saied,
"Prediction of 305 day milk yield from single and cumulative records of Holstein cows, using regression procedures.",
Proc. The 3rd All Africa Conference on Animal Agriculture and 11th Conference of the Egyptian Society of Animal production, Alexandria, Egypt, 6-9 November, vol. 37, no. Suppl. Issue: Egyptian Society of Animal Production, pp. 47–52, 2000.
Abstractn/a
]